Purchases and Sales Made in Q3 2023 in Bio Xcel Therapeutics, Inc. (BTAI)
This table provides information about the institutional ownership of Bio Xcel Therapeutics, Inc. (BTAI) during Q3 2023. The information is specifically focused on institutions that hold shares of BioXcel Therapeutics, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 14, 2023
Q3 2023
|
California State Teachers Retirement System
West Sacramento, CA |
SELL
|
- |
-1.76K- 7.24% |
$4.37K - $20.8K
|
22.5K
$53.1K
|
|
Nov 13, 2023
Q3 2023
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
SELL
|
- |
-1.87K- 86.17% |
$4.65K - $22.1K
|
300
$708
|
|
Oct 24, 2023
Q3 2023
|
Raymond James & Associates
St Petersburg, FL |
SELL
|
- |
-1.87K- 10.03% |
$4.66K - $22.2K
|
16.8K
$39.6K
|
|
Nov 13, 2023
Q3 2023
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-2.46K- 3.18% |
$6.13K - $29.2K
|
74.9K
$177K
|
|
Oct 12, 2023
Q3 2023
|
Sea Crest Wealth Management, LLC
Purchase, NY |
SELL
|
- |
-4.15K- 20.05% |
$10.3K - $49.2K
|
16.6K
$39.1K
|
|
Nov 14, 2023
Q3 2023
|
Legal & General Group PLC
London, X0 |
SELL
|
- |
-5.07K- 27.48% |
$12.6K - $60.1K
|
13.4K
$31.6K
|
|
Nov 14, 2023
Q3 2023
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-8.63K- 40.26% |
$21.5K - $102K
|
12.8K
$30.2K
|
|
Nov 13, 2023
Q3 2023
|
Credit Suisse Ag
Zurich, V8 |
SELL
|
- |
-9.91K- 31.49% |
$24.7K - $117K
|
21.6K
$50.9K
|
|
Nov 07, 2023
Q3 2023
|
New York State Common Retirement Fund
|
SELL
|
- |
-10.6K- 97.22% |
$26.5K - $126K
|
304
$717
|
|
Nov 09, 2023
Q3 2023
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-11.1K- 81.81% |
$27.6K - $131K
|
2.46K
$5.82K
|
|
Nov 14, 2023
Q3 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-11.2K- 7.76% |
$27.8K - $132K
|
133K
$314K
|
|
Nov 08, 2023
Q3 2023
|
Charles Schwab Investment Management Inc
San Francisco, CA |
SELL
|
- |
-11.4K- 7.67% |
$28.3K - $135K
|
137K
$323K
|
|
Nov 13, 2023
Q3 2023
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-18.5K- 7.56% |
$45.9K - $219K
|
226K
$533K
|
|
Nov 09, 2023
Q3 2023
|
Ubs Group Ag
|
SELL
|
- |
-32.3K- 29.14% |
$80.5K - $383K
|
78.6K
$186K
|
|
Nov 09, 2023
Q3 2023
|
Citigroup Inc
|
SELL
|
- |
-35.7K- 59.48% |
$89K - $423K
|
24.3K
$57.4K
|
|
Nov 13, 2023
Q3 2023
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-91.5K- 6.59% |
$228K - $1.08M
|
1.3M
$3.06M
|
|
Nov 07, 2023
Q3 2023
|
Barclays PLC
London, X0 |
SELL
|
- |
-93.1K- 92.4% |
$232K - $1.1M
|
7.66K
$18.1K
|
|
Nov 14, 2023
Q3 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-232K- 92.25% |
$577K - $2.74M
|
19.5K
$45.9K
|
|
Nov 14, 2023
Q3 2023
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
SELL
|
- |
-239K- 98.9% |
$596K - $2.84M
|
2.67K
$6.3K
|
|
Nov 14, 2023
Q3 2023
|
Wellington Management Group LLP
Boston, MA |
SELL
|
- |
-1.17M- 96.93% |
$2.9M - $13.8M
|
37K
$87.2K
|
|
Nov 14, 2023
Q3 2023
|
State Street Corp
Boston, MA |
SELL
|
- |
-1.66M- 80.22% |
$4.14M - $19.7M
|
410K
$967K
|
|
Nov 14, 2023
Q3 2023
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
SELL
|
- |
-1.75M- 89.76% |
$4.36M - $20.8M
|
200K
$472K
|